Nova Eye Medical Limited (ASX:EYE)

Nova Eye Medical Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 16, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	36	50	50	27	46	98
Market Cap Growth	-19.89%	-0.19%	87.27%	-41.43%	-52.91%	28.30%
Enterprise Value	37	49	50	16	20	99
Last Close Price	0.13	0.22	0.26	0.18	0.31	0.30
PE Ratio	-	-	-	-	-	2.74
Forward PE	-	-	-	-	-	295.65
PS Ratio	1.36	2.16	2.96	2.01	3.43	7.62
PB Ratio	2.04	2.36	2.17	0.89	1.30	0.97
P/TBV Ratio	3.60	3.52	3.42	1.16	1.44	1.00
P/FCF Ratio	-	-	-	-	-	19.01
P/OCF Ratio	-	-	-	-	-	18.08
EV/Sales Ratio	1.40	2.10	2.92	1.16	1.48	7.72
EV/FCF Ratio	-4.97	-	-	-	-	19.25
Debt / Equity Ratio	0.19	0.16	0.07	0.06	0.11	0.03
Debt / FCF Ratio	-	-	-	-	-	0.65
Asset Turnover	1.05	0.77	0.51	0.34	0.17	0.12
Inventory Turnover	1.01	0.77	0.72	0.71	0.77	0.21
Quick Ratio	0.98	1.80	1.68	3.05	4.96	6.93
Current Ratio	1.84	2.60	2.33	4.04	5.62	7.17
Return on Equity (ROE)	-49.77%	-39.49%	-57.08%	-22.81%	-6.41%	-12.19%
Return on Assets (ROA)	-21.93%	-18.61%	-21.98%	-15.42%	-3.91%	-4.11%
Return on Capital (ROIC)	-27.86%	-22.69%	-25.80%	-16.99%	-4.34%	-4.74%
Earnings Yield	-24.10%	-17.46%	-30.32%	-27.83%	-9.47%	36.51%
FCF Yield	-20.76%	-16.03%	-14.05%	-18.02%	-29.42%	5.26%
Buyback Yield / Dilution	-25.32%	-30.89%	-7.83%	-0.69%	-0.03%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.